Cyclic AMP enhancers and Abeta oligomerization blockers as potential therapeutic agents in Alzheimer's disease.
about
Kinetic and Structural Studies of Phosphodiesterase-8A and Implication on the Inhibitor Selectivity † ‡Structure-Based Discovery of Highly Selective Phosphodiesterase-9A Inhibitors and Implications for Inhibitor DesignNeuronal Gene Targets of NF-κB and Their Dysregulation in Alzheimer's Disease(-)-Epigallocatechin-3-gallate ameliorates learning and memory deficits by adjusting the balance of TrkA/p75NTR signaling in APP/PS1 transgenic mice.Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis.Activated Microglia-Induced Deficits in Excitatory Synapses Through IL-1β: Implications for Cognitive Impairment in Sepsis.Refolding and kinetic characterization of the phosphodiesterase-8A catalytic domain.Quenching of tryptophan fluorescence in the presence of 2,4-DNP, 2,6-DNP, 2,4-DNA and DNOC and their mechanism of toxicity.Wide distribution of CREM immunoreactivity in adult and fetal human brain, with an increased expression in dentate gyrus neurons of Alzheimer's as compared to normal aging brains.Neuroprotective actions of 2,4-dinitrophenol: Friend or foe?Angelica tenuissima Nakai ameliorates cognitive impairment and promotes neurogenesis in mouse model of Alzheimer's disease.The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease.Stimulation of p53 Transactivation Ability by Nicastrin in Mouse Fibroblasts
P2860
Q27652751-B83BF7AD-080F-47A5-9FC7-125D91ACD755Q27673292-31CA5657-8A23-479F-B9FA-1C27CCAEA3BFQ28074504-5496488D-1298-4593-9653-CE3E33DE98CAQ33574541-6EC08A73-4DAA-4EC0-92CD-41495848B246Q35327172-A690A856-2A27-46C5-A579-372CA02329B8Q41725625-6B98F106-79EB-4A69-BAE8-ABA079ECABB3Q41871350-EAF78204-304F-45CD-91E0-DE815F1838ECQ44670983-3378D872-D894-4B8F-BA24-602F7D6CE40BQ46848151-9B91F75B-6F8A-4206-96F7-DAD661CCADBEQ47131459-8F3FB92E-473B-4BB5-800D-1D14FC0473D3Q48018148-3F17A691-94C9-4C66-98AA-FFD30EECB94AQ50050282-76F9379C-A977-4B41-BEE1-957B900FD12DQ58650581-4C79A4B4-3CE6-4C2A-9A72-6DEA8C686822
P2860
Cyclic AMP enhancers and Abeta oligomerization blockers as potential therapeutic agents in Alzheimer's disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Cyclic AMP enhancers and Abeta ...... agents in Alzheimer's disease.
@en
type
label
Cyclic AMP enhancers and Abeta ...... agents in Alzheimer's disease.
@en
prefLabel
Cyclic AMP enhancers and Abeta ...... agents in Alzheimer's disease.
@en
P2093
P1476
Cyclic AMP enhancers and Abeta ...... agents in Alzheimer's disease
@en
P2093
Ana Paula Wasilewska-Sampaio
Anna Carolina A P Barbosa
Fernanda G De Felice
Sérgio T Ferreira
William L Klein
P304
P356
10.2174/156720507781077287
P577
2007-07-01T00:00:00Z